Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Epic Sciences, Predicine to Offer Liquid Biopsy Service for Biopharma Customers

Epic Sciences, Predicine to Offer Liquid Biopsy Service for Biopharma Customers

Oct 29, 2020
|
staff reporter

NEW YORK – Epic Sciences and Predicine said Thursday that they have entered into a global strategic partnership to offer biopharmaceutical companies access to liquid biopsy testing via both Predicine's circulating tumor DNA technology and Epic's circulating tumor cell platform.

Financial terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

European Regulators Begin Review of Sputnik V

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Irish Funding Agency Seeks Boost

Science reports that Science Foundation Ireland is seeking annual budget increases.

Lower Fees Sought

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

Nature Papers Examine Peregrine Falcon Migration Patterns, Tool to Search Single-Cell Data

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.

What's Popular?

In Business News

  1. Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

  2. C2i Genomics Acquires Sequencing Lab QNA Dx

  3. Olink Files For Public Offering in US

  4. Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience for up to $695M

  5. Agilent Prices $850M Senior Notes Offering

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.